ALDH5A1
Succinate-semialdehyde dehydrogenase, mitochondrial
As of the edition of 20 October 2026, ALDH5A1 (succinate-semialdehyde dehydrogenase, mitochondrial, UniProt P51649) has 1 drug tested at it and 5 companies on the list, 0 on route A and 2 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- P51649
- How well studied
- Drug target: an approved drug acts on it
- Where it sits in the cell
- Inside the cell
- Solved structures
- 5
- Disease areas
- Mental health; Nervous system; Cancer; Blood and lymph; Urinary and reproductive; Immune system; Pregnancy and women's health; Infections
- Registered trials of its drugs
- 270
Drugs at this target
| Status | Count |
|---|---|
| Marketed | 1 |
| Total | 1 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Valproic acid | Marketed | Phase 4 | none listed |
1 of 1 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Route B | 2 |
| Engaged | 3 |
| Total on the list | 5 |
The other 3 companies at ALDH5A1
In the product5 companies in all; 3 are not named here, and no score is.
See the 5 companies at ALDH5A1, ranked, with the facts behind eachRequest access. Nothing is shown until you do.